Wuhan YZY Biopharma Co., Ltd. (HKG:2496)
Hong Kong · Delayed Price · Currency is HKD 2.200
-0.005 (-0.23%)
Oct 9, 2026, 9:42 AM HKT
Wuhan YZY Biopharma Market Cap
Wuhan YZY Biopharma has a market cap or net worth of 484.62 million as of October 9, 2026. It is the 28,934th most valuable company in the world and the 1,448th biggest in Hong Kong. Its market cap has decreased by 63.18% in one year.
Market Cap
484.62M
Enterprise Value
556.95M
Revenue
67.26M
Global Rank
Country Rank
#1,448 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since September 25, 2023, Wuhan YZY Biopharma's market cap has decreased from 3.09B to 484.62M, a decrease of -84.31%. That is a compound annual growth rate of -45.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 484.62M | -68.83% |
| Dec 31, 2025 | 1.55B | -3.14% |
| Dec 31, 2024 | 1.61B | -6.97% |
| Dec 29, 2023 | 1.73B | -44.13% |
| Sep 25, 2023 | 3.09B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sunho Biologics | 970.43M |
| Kintor Pharmaceutical | 807.38M |
| Brii Biosciences | 620.79M |
| 3D Medicines | 587.75M |
| B&K Corporation | 493.57M |
| Uni-Bio Science Group | 417.99M |
| Sirnaomics | 413.27M |
| Transcenta Holding | 345.83M |